相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel way to quantify schizophrenia symptoms in clinical trials
Oleg N. Medvedev et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
N-Acetylcysteine Attenuates the Anxiety-Like Behavior and Spatial Cognition Impairment Induced by Doxorubicin and Cyclophosphamide Combination Treatment in Rats
Yoshihisa Kitamura et al.
PHARMACOLOGY (2021)
An organization- and category-level comparison of diagnostic requirements for mental disorders in ICD-11 and DSM-5
Michael B. First et al.
WORLD PSYCHIATRY (2021)
Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study
Alberto Papi et al.
ADVANCES IN THERAPY (2021)
N-Acetylcysteine treatment during acute stress prevents stress-induced augmentation of addictive drug use and relapse
Constanza Garcia-Keller et al.
ADDICTION BIOLOGY (2020)
Sex influences in the preventive effects of N-acetylcysteine in a two-hit animal model of schizophrenia
Aline Santos Monte et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with bipolar disorder: A sub-study of a randomised placebo-controlled trial
Melanie M. Ashton et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia
Caitlin O. B. Yolland et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial
Sudie E. Back et al.
CONTEMPORARY CLINICAL TRIALS (2020)
N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study
Fenghua Li et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2020)
Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease
Irena Smaga et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions
Emma J. Mitchell et al.
SCIENTIFIC REPORTS (2020)
N-Acetylcysteine Rescues Hippocampal Oxidative Stress-Induced Neuronal Injury via Suppression of p38/JNK Signaling in Depressed Rats
Cuiqin Fan et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
The effects of N-Acetylcysteine on serum level of inflammatory biomarkers in adults. Findings from a systematic review and meta-analysis of randomized clinical trials
Mohammadreza Askari et al.
CYTOKINE (2020)
Reduction of anxiety level is associated with an oxidative-stress imbalance in the hippocampus in morphine administration period in male rats
Hamidreza Famitafreshi et al.
JOURNAL OF ADDICTIVE DISEASES (2020)
Slc7a11 (xCT) protein expression is not altered in the depressed brain and system xc- deficiency does not affect depression-associated behaviour in the corticosterone mouse model
Thomas Demuyser et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
N-Acetylcysteine Reverses Anxiety and Oxidative Damage Induced by Unpredictable Chronic Stress in Zebrafish
Ricieri Mocelin et al.
MOLECULAR NEUROBIOLOGY (2019)
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Michael Berk et al.
BMC MEDICINE (2019)
The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study
Pernille Kempel Ellegaard et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Targeting the immune system in the treatment of bipolar disorder
Joshua D. Rosenblat
PSYCHOPHARMACOLOGY (2019)
N-acetylcysteine attenuates neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat
Joneth Fernandes et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
The Behavioral Sequelae of Social Defeat Require Microglia and Are Driven by Oxidative Stress in Mice
Michael L. Lehmann et al.
JOURNAL OF NEUROSCIENCE (2019)
Increased Fear Memory and Glutamatergic Modulation in Compulsive Drinker Rats Selected by Schedule-Induced Polydipsia
Angeles Prados-Pardo et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
Neuroinflammation as a risk factor for attention deficit hyperactivity disorder
Geoffrey A. Dunn et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
N-acetyl cysteine inhibits lipopolysaccharide-mediated synthesis of interleukin-1β and tumor necrosis factor-α in human periodontal ligament fibroblast cells through nuclear factor-kappa B signaling
Rui Zheng et al.
MEDICINE (2019)
Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: a review
Patricia Santos et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
COX-2 inhibition rescues depression-like behaviors via suppressing glial activation, oxidative stress and neuronal apoptosis in rats
Qiqi Song et al.
NEUROPHARMACOLOGY (2019)
N-Acetylcysteine Protects against the Anxiogenic Response to Cisplatin in Rats
Rade Vukovic et al.
BIOMOLECULES (2019)
A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression
Isabelle E. Bauer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2019)
N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges
Twanette Swanepoel et al.
PSYCHOPHARMACOLOGY (2018)
Effects of N-acetylcysteine on amphetamine-induced sensitization in mice
Ana P. Herrmann et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2018)
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
Philippe Conus et al.
SCHIZOPHRENIA BULLETIN (2018)
Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression
Bruna Panizzutti et al.
ACTA NEUROPSYCHIATRICA (2018)
N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials
W. Zheng et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
N-Acetylcysteine Blocks Serotonin 1B Agonist-Induced OCD-Related Behavior in Mice
Emily M. Allen et al.
BEHAVIORAL NEUROSCIENCE (2018)
ω-3 and folic acid act against depressive-like behavior and oxidative damage in the brain of rats subjected to early- or late-life stress
Gislaine Z. Reus et al.
NUTRITION (2018)
Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial
Zahra Sepehrmanesh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Effects of adjunctive N-acetylcysteine on depressive symptoms: Modulation by baseline high-sensitivity C-reactive protein
Mauro Porcu et al.
PSYCHIATRY RESEARCH (2018)
Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression
Bruna Panizzutti et al.
ACTA NEUROPSYCHIATRICA (2018)
Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders
Alan Breier et al.
SCHIZOPHRENIA RESEARCH (2018)
RGS4 deficit in prefrontal cortex contributes to the behaviors related to schizophrenia via system xc--mediated glutamatergic dysfunction in mice
Min-Wei Huang et al.
THERANOSTICS (2018)
Metoprolol, N-Acetylcysteine, and Escitalopram Prevents Chronic Unpredictable Mild Stress-Induced Depression by Inhibition of Endoplasmic Reticulum Stress
Lixia Yang et al.
FRONTIERS IN PSYCHIATRY (2018)
Role of Novel Dietary Supplement N-acetyl Cysteine in Treating Negative Symptoms in Schizophrenia: A 6-Month Follow-up Study
Hema Tharoor et al.
INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE (2018)
Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among US Children and Adolescents, 2016
Melissa L. Danielson et al.
JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY (2018)
Cognitive effects of adjunctive N-acetyl cysteine in psychosis
M. Rapado-Castro et al.
PSYCHOLOGICAL MEDICINE (2017)
Obsessive-Compulsive Disorder Advances in Diagnosis and Treatment
Matthew E. Hirschtritt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder
Daniel L. C. Costa et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor
Kyoko Hasebe et al.
ACTA NEUROPSYCHIATRICA (2017)
Antioxidant Treatment in Male Mice Prevents Mitochondrial and Synaptic Changes in an NMDA Receptor Dysfunction Model of Schizophrenia
Aarron Phensy et al.
ENEURO (2017)
Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis
Dan Siskind et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Anxiolytic properties of N-acetylcysteine in mice
Patricia Santos et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Development and validation of a question prompt list for parents of children with attention-deficit/hyperactivity disorder: a Delphi study
Rana Ahmed et al.
HEALTH EXPECTATIONS (2016)
Evidence for Epigenetic Regulation of Pro-Inflammatory Cytokines, Interleukin-12 and Interferon Gamma, in Peripheral Blood Mononuclear Cells from PTSD Patients
Marpe Bam et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice
M. S. Bowers et al.
PSYCHOPHARMACOLOGY (2016)
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
Susan L. Rossell et al.
BMC PSYCHIATRY (2016)
N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial
K. Paydary et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2016)
A double-Blind, Randomized,Controlled pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders
Sudie E. Back et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
N-acetylcysteine amide (AD4) reduces cocaine-induced reinstatement
Joanna Jastrzebska et al.
PSYCHOPHARMACOLOGY (2016)
Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats
Kalyan N. Rao et al.
PSYCHOPHARMACOLOGY (2016)
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A central hub in schizophrenia pathophysiology?
P. Steullet et al.
SCHIZOPHRENIA RESEARCH (2016)
N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study
Jerome Sarris et al.
CNS DRUGS (2015)
Complete Remission of Obsessive Compulsive Disorder After N-acetylcystein Treatment
S. Saraiva et al.
EUROPEAN PSYCHIATRY (2015)
N-Acetylcysteine Augmentation in Children and Adolescents Diagnosed With Treatment-Resistant Obsessive-Compulsive Disorder Case Series
Kemal Utku Yazici et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism
Irena Smaga et al.
PHARMACOLOGICAL REPORTS (2015)
Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain
Andrzej Moniczewski et al.
PHARMACOLOGICAL REPORTS (2015)
N-acetylcysteine prevents stress-induced anxiety behavior in zebrafish
Ricieri Mocelin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Targeting Glia with N-Acetylcysteine Modulates Brain Glutamate and Behaviors Relevant to Neurodevelopmental Disorders in C57BL/6J Mice
Alice M. S. Durieux et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement
Kathryn J. Reissner et al.
ADDICTION BIOLOGY (2015)
Effects of N-acetylcysteine and imipramine in a model of acute rhythm disruption in BALB/c mice
Luisa K. Pilz et al.
CHRONOBIOLOGY INTERNATIONAL (2015)
An Open-Label Pilot Study of N-Acetylcysteine for Skin-Picking in Prader-Willi Syndrome
Jennifer L. Miller et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries
Justin Davis et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
The effects of N-acetylcysteine on cocaine reward and seeking behaviors in a rat model of depression
Malgorzata Frankowska et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
The Endocannabinoid/Endovanilloid System and Depression
Irena Smaga et al.
CURRENT NEUROPHARMACOLOGY (2014)
The Role of Glutamatergic Dysfunction in Treatment-Resistant Obsessive-Compulsive Disorder: Treatment of an Adolescent Case with N-Acetylcysteine Augmentation
Kemal Utku Yazici et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2014)
The Efficacy of Adjunctive N-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial
Michael Berk et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia
Jan-Harry Cabungcal et al.
NEURON (2014)
N-acetylcysteine modulates hallucinogenic 5-HT2A receptor agonist-mediated responses: Behavioral, molecular, and electrophysiological studies
Mei-Yi Lee et al.
NEUROPHARMACOLOGY (2014)
N-acetylcysteine in the treatment of skin-picking disorder
Regina Silva-Netto et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2014)
N-acetylcysteine prevents increased amphetamine sensitivity in social isolation-reared mice
Ana P. Herrmann et al.
SCHIZOPHRENIA RESEARCH (2014)
Activation of rinGluR2/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism
Yu-Wen Chen et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
Attention Deficit and Hyperactivity Disorder Scores Are Elevated and Respond to N-Acetylcysteine Treatment in Patients With Systemic Lupus Erythematosus
Ricardo J. Garcia et al.
ARTHRITIS AND RHEUMATISM (2013)
A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania
Pedro Vieira da Silva Magalhaes et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo
Pritha Das et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
A Critical Review of Magnetic Resonance Spectroscopy Studies of Obsessive-Compulsive Disorder
Brian P. Brennan et al.
BIOLOGICAL PSYCHIATRY (2013)
Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine
Marisa Moeller et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases
Mary J. Holmay et al.
CLINICAL NEUROPHARMACOLOGY (2013)
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
Mehdi Farokhnia et al.
CLINICAL NEUROPHARMACOLOGY (2013)
N-Acetylcysteine Augmentation to Tranylcypromine in Treatment-Resistant Major Depression
André F. Carvalho et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
N-Acetylcysteine in the Treatment of Pediatric Trichotillomania: A Randomized, Double-Blind, Placebo-Controlled Add-On Trial
Michael H. Bloch et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2013)
N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats
Marisa Moeller et al.
METABOLIC BRAIN DISEASE (2013)
Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc- activity in the medial prefrontal cortex
Victoria Lutgen et al.
PSYCHOPHARMACOLOGY (2013)
N-acetylcysteine augmentation in treatment resistant obsessive compulsive disorder: A case series
Michael Van Ameringen et al.
JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS (2013)
N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development
Joao Miguel das Neves Duarte et al.
BIOLOGICAL PSYCHIATRY (2012)
Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
Michael Berk et al.
BMC MEDICINE (2012)
Treatment with Adjunctive N-Acetylcysteine in an Adolescent with Selective Serotonin Reuptake Inhibitor-Resistant Anxiety
Jeffrey R. Strawn et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2012)
N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial
Hamid Afshar et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
N-Acetyl-L-Cysteine Inhibits Marble-Burying Behavior in Mice
Nobuaki Egashira et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats
Camila O. Arent et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Biomarkers of PTSD: Neuropeptides and immune signaling
Dewleen G. Baker et al.
NEUROPHARMACOLOGY (2012)
N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study
Lianne Schmaal et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial
Cristian Carmeli et al.
PLOS ONE (2012)
N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: Behavioral and biochemical analyses in rats
Irena Smaga et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Effects of N-acetyl cysteine on cognitive function in bipolar disorder
Olivia M. Dean et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2012)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages
J. R. Palacio et al.
INFLAMMATION RESEARCH (2011)
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial
Michael Berk et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial
P. V. Magalhaes et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and D-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder
Olivia M. Dean et al.
NEUROSCIENCE LETTERS (2011)
N-acetylcysteine for major depressive episodes in bipolar disorder
Pedro V. Magalhaes et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2011)
Efficacy of N-Acetylcysteine in the Treatment of Nicotine Dependence: A Double-Blind Placebo-Controlled Pilot Study
Lianne Schmaal et al.
EUROPEAN ADDICTION RESEARCH (2011)
TRICHOTILLOMANIA (HAIR PULLING DISORDER), SKIN PICKING DISORDER, AND STEREOTYPIC MOVEMENT DISORDER: TOWARD DSM-V
Dan J. Stein et al.
DEPRESSION AND ANXIETY (2010)
Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats
Kwok Ho Christopher Choy et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
P03-101 N-Acetyl-cysteine in augmentation to atypical antipsychotics improves cognitive symptoms in subjects with schizophrenia
A.E. Di Rosa et al.
EUROPEAN PSYCHIATRY (2010)
Relationship of Possible Stress-Related Biochemical Markers to Oxidative/Antioxidative Status in Obsessive-Compulsive Disorder
A. Behl et al.
NEUROPSYCHOBIOLOGY (2010)
The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice
Hwei-Hsien Chen et al.
PSYCHOPHARMACOLOGY (2010)
N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania A Double-blind, Placebo-Controlled Study
Jon E. Grant et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
2007 National Survey of Mental Health and Wellbeing: methods and key findings
Tim Slade et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2009)
Nail-Biting Stuff? The Effect of N-acetyl Cysteine on Nail-Biting
Michael Berk et al.
CNS SPECTRUMS (2009)
Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive-Compulsive Disorder
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder
Ercan Ozdemir et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia
Mahmut Bulut et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
Relationship of cognition and psychopathology to functional impairment in schizophrenia
Somaia Mohamed et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder
Murat Yuecel et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2008)
Antidepressant-like effects of N-acetyl-L-cysteine in rats
Frederico F. Ferreira et al.
BEHAVIOURAL PHARMACOLOGY (2008)
N-acetyl cysteine for depressive symptoms in bipolar disorder - A double-blind randomized placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine
David A. Baker et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients
Suzie Lavoie et al.
NEUROPSYCHOPHARMACOLOGY (2008)
N-acetyl cysteine in the treatment of grooming disorders
Brian L. Odlaug et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder
Serpil Ersan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder
DL Lafleur et al.
PSYCHOPHARMACOLOGY (2006)
Glutamatergic dysfunction in OCD
K Chakrabarty et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse
DA Baker et al.
NATURE NEUROSCIENCE (2003)
分享论文
